Advertisement

Topics

Profile Therapeutics plc Company Profile

14:58 EDT 22nd September 2017 | BioPortfolio

In 1994, the business was acquired by its management in order to progress the development of its innovative platform "intelligent inhalation" technology known as Adaptive Aerosol Delivery™ or "AAD™". In March 2000, Profile Therapeutics plc completed its IPO on the London Stock Exchange to exploit the opportunities presented by this technology.

Profile Therapeutics plc now comprises three complementary businesses, each with its own focus in the area of drug delivery but with a shared common aim.



To improve the lives and therapy of the young, the elderly and patients with impaired breathing who present a challenge to treatment.

Location

Heath Place
Bognor Regis
PO22 9SL
United Kingdom

Contact

Phone: 01243 840 033
Fax: 01243 846 146
Email: paul.probets@profiletherapeutics.com


News Articles [2782 Associated News Articles listed on BioPortfolio]

Concurrent with BMS acquisition, IFM Therapeutics spins off IFM Therapeutics LLC

Innate immunity-focused IFM Therapeutics is spinning off its non-oncology assets into the new company IFM Therapeutics LLC.

Sanofi-Backed Voyager Therapeutics Hails Gene Therapy's Arrival

Emerging Company Profile: With a pipeline of products for neurological diseases and a collaboration with Sanofi's Genzyme, Voyager Therapeutics is...   

ProQR spins out Amylon Therapeutics for CNS therapeutics

ProQR Therapeutics has spun out Amylon Therapeutics, a privately-held company focused on the development of therapies for central nervous system (CNS) disorders, with seed funding from a group of inst...

ImCheck Therapeutics Pursues Immuno-Oncology Antibodies

Emerging Company Profile: The new anticancer antibody developer ImCheck Therapeutics has set up in Marseille, France, a location that...   

Summit Therapeutics PLC (SMMT) and Orexigen Therapeutics (OREX) Head to Head Review

Summit Therapeutics PLC and Orexigen Therapeutics are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, in...

Iterum Therapeutics Focused On First Oral Penem

Emerging Company Profile: Iterum Therapeutics is developing a Phase III-ready penem antibiotic, sulopenem, which could be the first in its...   

RaNA Therapeutics Relaunches as Translate Bio to Advance RNA Therapeutics

Tuesday, June 27th 2017 at 11:00am UTC — Company Expands Executive Leadership Team with Key Appointments in Early 2017 — CAMBRIDGE, Mass.–(BUSINESS WIRE)– RaNA Therapeutics tod...

CRISPR Therapeutics and Neon Therapeutics Enter Research Collaboration

CAMBRIDGE, Mass. and BASEL, Switzerland, July 10, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines...

PubMed Articles [1319 Associated PubMed Articles listed on BioPortfolio]

In Vitro Evaluation of the Ophthalmic Toxicity Profile of Chlorhexidine and Propamidine Isethionate Eye Drops.

Acanthamoeba keratitis causes frequent epithelial lesions that fully expose the corneal stroma. The aim of this study was to determine the toxic profile of chlorhexidine and propamidine eye drops.

Response to Aslankurt et al. re: "Safety Profile of Stromal Hydration of Clear Corneal Incisions with Cefuroxime in the Mouse Model".

Re: "Safety Profile of Stromal Hydration of Clear Corneal Incisions with Cefuroxime in the Mouse Model" by Moosajee et al. (J. Ocul. Pharmacol. Ther. 32:469-475, 2016).

Profile: InterveXion Therapeutics.

Prevalence of odontogenic lesions among the Kanpur population: an institutional study.

The frequency and incidence of odontogenic cysts and tumors are controversial and depends in the geographic location. These lesions have great clinical and histopathological diversity, and reflect a n...

Clinical Trials [1882 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

IFM2009-02-Pomalidomide and Dexamethasone Phase 2 Myeloma

The purpose of this study is to evaluate the response to pomalidomide and dexamethasone in relapse and refractory MM patients who are progressive and did not achieve at least a partial res...

Companies [1336 Associated Companies listed on BioPortfolio]

Profile Therapeutics plc

In 1994, the business was acquired by its management in order to progress the development of its innovative platform "intelligent inhalation" technology known as Adaptive Aerosol Delivery™ or "AAD...

Profile Therapeutics Inc

Many of our customers have known us for a long time as Medic-Aid, manufacturers of quality drug delivery systems for patients and the healthcare sector, for nearly 25 years. Profile Respiratory System...

Strategia Therapeutics, Inc.

【Startegia Therapeutics, Inc. Profile】

Profile Therapeutics

Nil

Biologist Network

Each registered (french speaking) user in the directory has its own profile (for an example, click here). The user can access his profile at any time to modify it (or even to delete it). Each profile ...

More Information about "Profile Therapeutics plc" on BioPortfolio

We have published hundreds of Profile Therapeutics plc news stories on BioPortfolio along with dozens of Profile Therapeutics plc Clinical Trials and PubMed Articles about Profile Therapeutics plc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Profile Therapeutics plc Companies in our database. You can also find out about relevant Profile Therapeutics plc Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record